Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families
- PMID: 20637093
- PMCID: PMC2949638
- DOI: 10.1186/bcr2608
Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families
Abstract
Introduction: A significant proportion of high-risk breast cancer families are not explained by mutations in known genes. Recent genome-wide searches (GWS) have not revealed any single major locus reminiscent of BRCA1 and BRCA2, indicating that still unidentified genes may explain relatively few families each or interact in a way obscure to linkage analyses. This has drawn attention to possible benefits of studying populations where genetic heterogeneity might be reduced. We thus performed a GWS for linkage on nine Icelandic multiple-case non-BRCA1/2 families of desirable size for mapping highly penetrant loci. To follow up suggestive loci, an additional 13 families from other Nordic countries were genotyped for selected markers.
Methods: GWS was performed using 811 microsatellite markers providing about five centiMorgan (cM) resolution. Multipoint logarithm of odds (LOD) scores were calculated using parametric and nonparametric methods. For selected markers and cases, tumour tissue was compared to normal tissue to look for allelic loss indicative of a tumour suppressor gene.
Results: The three highest signals were located at chromosomes 6q, 2p and 14q. One family contributed suggestive LOD scores (LOD 2.63 to 3.03, dominant model) at all these regions, without consistent evidence of a tumour suppressor gene. Haplotypes in nine affected family members mapped the loci to 2p23.2 to p21, 6q14.2 to q23.2 and 14q21.3 to q24.3. No evidence of a highly penetrant locus was found among the remaining families. The heterogeneity LOD (HLOD) at the 6q, 2p and 14q loci in all families was 3.27, 1.66 and 1.24, respectively. The subset of 13 Nordic families showed supportive HLODs at chromosome 6q (ranging from 0.34 to 1.37 by country subset). The 2p and 14q loci overlap with regions indicated by large families in previous GWS studies of breast cancer.
Conclusions: Chromosomes 2p, 6q and 14q are candidate sites for genes contributing together to high breast cancer risk. A polygenic model is supported, suggesting the joint effect of genes in contributing to breast cancer risk to be rather common in non-BRCA1/2 families. For genetic counselling it would seem important to resolve the mode of genetic interaction.
Figures


Similar articles
-
Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus.Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9603-8. doi: 10.1073/pnas.97.17.9603. Proc Natl Acad Sci U S A. 2000. PMID: 10944226 Free PMC article.
-
Genome-wide linkage scan in Dutch hereditary non-BRCA1/2 breast cancer families identifies 9q21-22 as a putative breast cancer susceptibility locus.Genes Chromosomes Cancer. 2008 Nov;47(11):947-56. doi: 10.1002/gcc.20597. Genes Chromosomes Cancer. 2008. PMID: 18663745
-
Whole-genome Linkage Analysis and Sequence Analysis of Candidate Loci in Familial Breast Cancer.Anticancer Res. 2015 Jun;35(6):3155-65. Anticancer Res. 2015. PMID: 26026075
-
Recent progress in the genetics of common obesity.Br J Clin Pharmacol. 2009 Dec;68(6):811-29. doi: 10.1111/j.1365-2125.2009.03523.x. Br J Clin Pharmacol. 2009. PMID: 20002076 Free PMC article. Review.
-
Polygenic susceptibility to breast cancer: current state-of-the-art.Future Oncol. 2009 Jun;5(5):689-701. doi: 10.2217/fon.09.29. Future Oncol. 2009. PMID: 19519208 Free PMC article. Review.
Cited by
-
Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers.Br J Cancer. 2016 Sep 27;115(7):776-83. doi: 10.1038/bjc.2016.249. Epub 2016 Aug 18. Br J Cancer. 2016. PMID: 27537391 Free PMC article.
-
The Genetic Analyses of French Canadians of Quebec Facilitate the Characterization of New Cancer Predisposing Genes Implicated in Hereditary Breast and/or Ovarian Cancer Syndrome Families.Cancers (Basel). 2021 Jul 7;13(14):3406. doi: 10.3390/cancers13143406. Cancers (Basel). 2021. PMID: 34298626 Free PMC article. Review.
-
The cyclin-like protein Spy1/RINGO promotes mammary transformation and is elevated in human breast cancer.BMC Cancer. 2012 Jan 26;12:45. doi: 10.1186/1471-2407-12-45. BMC Cancer. 2012. PMID: 22280365 Free PMC article.
-
Genome-wide association study of hepatocellular carcinoma in Southern Chinese patients with chronic hepatitis B virus infection.PLoS One. 2011;6(12):e28798. doi: 10.1371/journal.pone.0028798. Epub 2011 Dec 8. PLoS One. 2011. PMID: 22174901 Free PMC article.
-
Double Heterozygosity of BRCA2 and STK11 in Familial Breast Cancer Detected by Exome Sequencing.Iran J Public Health. 2015 Oct;44(10):1348-52. Iran J Public Health. 2015. PMID: 26576347 Free PMC article.
References
-
- Arason A, Jonasdottir A, Barkardottir RB, Bergthorsson JT, Teare MD, Easton DF, Egilsson V. A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland. J Med Genet. 1998;35:446–449. doi: 10.1136/jmg.35.6.446. - DOI - PMC - PubMed
-
- Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M. The Breast Cancer Linkage Consortium. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet. 1998;62:676–689. doi: 10.1086/301749. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous